Velcade in MALT Lymphoma Patients

PHASE2CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

Not specified

Conditions
MALT Lymphoma
Interventions
DRUG

Bortezomib (Velcade)

All Listed Sponsors
lead

Medical University of Vienna

OTHER